BIOFRONTERA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.84 USD | +6.35% |
|
+23.08% | -33.57% |
| Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
| Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar Biofrontera Inc.
4194d485f882cc187b86.E755vtQ4xHVWyqOsyZ5mEd-UwL6VoJGtfd0IPI5w_04.WNof0ZFuoTkznfP9n-0pTur2qP3smNrVFYpvS-o3iih0-iPYtmuwEGarwA~8665328ed5545bc38e884e9e3c841504
Upcoming events on Biofrontera Inc.
Past events on Biofrontera Inc.
| 2024-04-24 10:00 am | Extraordinary Shareholders Meeting |
| 2024-03-19 11:30 am | Roth Conference |
| 2024-03-18 10:00 am | Q4 2023 Earnings Call |
| 2024-03-15 06:10 pm | Q4 2023 Earnings Release |
| 2023-12-19 | Annual General Meeting |
| 2023-11-10 10:00 am | Q3 2023 Earnings Call |
| 2023-11-09 05:10 pm | Q3 2023 Earnings Release |
| 2023-10-18 | Fall Clinical Dermatology Conference - Cosmetic and Clinical Outcomes |
| 2023-10-18 | Fall Clinical Dermatology Conference - Multicenter Phase-III-Trial |
| 2023-10-18 | Fall Clinical Dermatology Conference - A Cross-Sectional Study From 2015-2022 |
| 2023-10-12 09:15 am | Roth Healtcare Opportunities Conference |
| 2023-08-11 08:30 am | Q2 2023 Earnings Call |
| 2023-08-11 07:00 am | Q2 2023 Earnings Release |
| 2023-05-21 | Extraordinary Shareholders Meeting |
| 2023-05-12 08:30 am | Q1 2023 Earnings Call |
| 2023-05-12 08:30 am | Q1 2023 Earnings Release |
| 2023-03-13 11:00 am | ROTH Conference |
| 2023-03-08 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-08 04:03 pm | Q4 2022 Earnings Release |
| 2023-02-21 10:00 am | Winter Wonderland Best Ideas Investor Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 24,1 24,2 -0.22% | 28,7 28,9 -0.69% | 34,1 34,1 -0.14% | 40,7 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -25,2 -25,5 1.17% | -18,6 -18,1 -2.87% | -22,7 -21,4 -6.17% | -13,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -37,7 -25,3 -48.66% | -0,61 -0,91 33.48% | -20,1 -26,2 23.36% | -16,0 |
|
Net income Million USD | Released Forecast Spread | -11,0 | -37,7 -25,4 -48.36% | -0,64 -0,93 31.11% | -20,1 -26,3 23.33% | -16,0 |
|
EPS USD | Released Forecast Spread | -9 590 | -85,6 -55,9 -53.13% | -0,60 -0,90 33.33% | -13,0 -16,8 22.38% | -3,25 |
| Announcement Date | 07/05/21 | 08/04/22 | 08/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,17 9,24 -0.75% | 9,75 9,83 -0.82% | 4,46 4,54 -1.8% | 4,32 4,31 0.32% | 10,1 10,4 -2.07% | 8,73 9,10 -4.03% | 5,85 6,18 -5.37% | 8,90 8,43 5.48% | 10,6 10,6 -0.44% | 10,9 | 8,61 | 7,96 | 13,3 | 12,5 |
|
EBIT Million USD | Released Forecast Spread | -1,88 -2,19 14.1% | -3,11 -2,40 -29.58% | -6,21 -6,25 0.55% | -3,64 -6,80 46.45% | -5,62 -3,03 -85.36% | -5,49 -4,50 -22.04% | -8,70 -6,29 -38.29% | -4,62 -5,39 14.22% | -3,87 -2,60 -48.4% | -3,34 | -4,42 | -5,56 | 0,08 | -1,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,5 -2,20 -558.04% | 5,59 -2,40 332.96% | -0,85 -6,24 86.39% | -2,57 -6,82 62.37% | -2,78 -3,05 8.78% | -7,47 -4,40 -69.84% | -9,82 -6,32 -55.54% | -6,34 -5,41 -17.19% | 3,52 -2,63 233.87% | -4,70 | -5,78 | -5,59 | 0,05 | -1,00 |
|
Net income Million USD | Released Forecast Spread | -14,5 -2,22 -554.56% | 5,56 -2,40 331.71% | -0,85 -6,26 86.41% | -2,57 -6,82 62.35% | -2,79 -3,05 8.75% | -7,48 -4,40 -69.95% | -9,84 -6,32 -55.76% | -6,34 -5,41 -17.21% | 3,53 -2,63 234.09% | -4,70 | -5,78 | -5,59 | 0,05 | -1,00 |
|
EPS USD | Released Forecast Spread | -25,8 -3,60 -616.67% | 6,40 -3,20 300% | -1,00 -6,80 85.29% | -2,20 -5,80 62.07% | -2,80 -2,20 -27.27% | -5,60 -3,90 -43.59% | -7,23 -4,61 -56.83% | -4,64 -3,79 -22.59% | 4,55 -1,19 482.35% | -1,17 | -1,13 | -1,08 | 0,01 | -0,19 |
| Announcement Date | 08/04/22 | 13/05/22 | 12/08/22 | 14/11/22 | 08/03/23 | 12/05/23 | 11/08/23 | 09/11/23 | 15/03/24 | - | - | - | - | - |
| Today 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 2024-05-01 | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-02 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Biofrontera Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BFRI Stock
- Calendar Biofrontera Inc.
